During the past decade, Avrora MedFort, LLC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avrora MedFort, LLC" #1 collaborator was "Sponsor GmbH" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Avrora MedFort, LLC" are "COVID-19" (2 trials). Many other conditions were trialed in "Avrora MedFort, LLC" in a lesser frequency.

Most popular intervention types in "Avrora MedFort, LLC" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Standard of care" (2 trials), "Molnupiravir (Esperavir)" (1 trials) and "nirmatrelvir/ritonavir" (1 trials). Other intervention names were less common.

The vast majority of trials in "Avrora MedFort, LLC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Avrora MedFort, LLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Avrora MedFort, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Avrora MedFort, LLC, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".